Cargando…
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
The global spread of carbapenem-resistant Enterobacteriaceae (CRE) is increasingly becoming a major challenge in clinical and public health settings. To date, the treatment for serious CRE infections remains difficult. The intelligent use of antimicrobials and effective infection control strategies...
Autores principales: | Yamamoto, Michele, Pop-Vicas, Aurora E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075344/ https://www.ncbi.nlm.nih.gov/pubmed/25041592 http://dx.doi.org/10.1186/cc13949 |
Ejemplares similares
-
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
por: Morrill, Haley J., et al.
Publicado: (2015) -
Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
por: Sheu, Chau-Chyun, et al.
Publicado: (2019) -
Therapeutic Options for the Treatment of Carbapenem-resistant Enterobacteriaceae Infections: Hope in the Times of Hype and Despair
por: Ansari, Abdul S
Publicado: (2021) -
Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021) -
What have we learned and what do we still need to learn about nPDF?
por: Paakkinen, Petja
Publicado: (2021)